An assessment of the developmental toxicity of inorganic arsenic

Reproductive Toxicology

Volumn 12, Issue 4, 1998, Pages 385-433

  Desesso, John M ^a   Jacobson, Catherine F ^a   Scialli, Anthony R ^b   Farr, Craig H ^c   Holson, Joseph F ^d  

^a NOBLIS   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c Elf Atochem North America Inc   (United States)

^d WIL RESEARCH LABORATORIES   (United States)

Author keywords

Animal; Arsenic; Developmental toxicity; Human; Neural tube defects; Teratogenicity

Indexed keywords

ARSENIC; ARSENIC DERIVATIVE;

AIRBORNE PARTICLE; ANIMAL; CONGENITAL MALFORMATION; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; EXENCEPHALY; FEMALE; FETUS; HUMAN; IATROGENIC DISEASE; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; ORGAN CULTURE; PREGNANCY; PRENATAL EXPOSURE; PROGENY; RABBIT; RAT; REPRODUCTION; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; SMELTER; TERATOGENICITY; WATER POLLUTANT;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ARSENIC; FEMALE; FETUS; HUMANS; MICE; NEURAL TUBE DEFECTS; ORGAN CULTURE TECHNIQUES; PREGNANCY; RABBITS; RATS; REPRODUCTION; WATER POLLUTANTS, CHEMICAL;

EID: 0032129095     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(98)00021-5     Document Type: Review

References (205)

1. Boyle R.W., Jonasson I.R. The geochemistry of arsenic and its use as an indicator element in geochemical prospecting. J Geochem Explor. 2:1973;251-296.
2. Tamaki S., Frankenberger W.T. Jr. Environmental biochemistry of arsenic. Rev Environ Contam Toxicol. 124:1992;79-110.
3. th ed, vol. 1. 1982;715-718 McGraw-Hill, New York.
4. International Agency for Research on Cancer (IARC), World Health Organization. Arsenic and arsenic compounds. In: IARC monographs on the evaluation of carcinogenic risk of chemicals to man, vol. 23, Some metals and metallic compounds. Lyon: IARC; 1980:39-141.
5. Aposhian H.V. Biochemical toxicology of arsenic. Rev Biochem Toxicol. 10:1989;265-299.
6. Vallee B.L., Ulmer D.D., Wacker W.E.C. Arsenic toxicology and biochemistry. AMA Arch Industr Health. 21:1960;132-151.
7. Klaassen C.D. Heavy metals and heavy metal antagonists. Gilman A.G., Rall T.W., Nies A.S., Taylor P. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. 1990;1592-1614 McGraw-Hill, New York.
8. Winship K.A. Toxicity of inorganic arsenic salts. Adverse Drug React Acute Poisoning Rev. 3:1984;129-160.
9. Neubauer O. Arsenical cancer a review . Br J Cancer. 1:1947;192-251.
10. U. S. Department of Health and Human Services, Public Health Service. Arsenic and certain arsenic compounds. In: Fifth annual report on carcinogens: summary. NTP 89-239. Washington, DC: U. S. Government Printing Office; 1989:3-8.
11. Integrated Risk Information Service (IRIS), U. S. Environmental Protection Agency. IRIS substance file: arsenic, inorganic. Web page http://www.epa.gov/ngispgm3/iris/subst/0278.htm. March. 1997.
12. Shepard T.H. Catalog of teratogenic agents. 8th ed. 1995;Johns Hopkins, Baltimore.
13. Schardein J.L. Chemically induced birth defects. 1985;Marcel Dekker, New York.
14. Barlow S.M., Sullivan F.M. Reproductive hazards of industrial chemicals an evaluation of animal and human data . 1982;Marcel Dekker, New York.
15. Nisbet I.C.T., Karch N.J. Chemical hazards to human reproduction. 1983;Noyes Data Corp, Park Ridge, NJ.
16. Hemminki K., Vineis P. Extrapolation of evidence on teratogenicity of chemicals between humans and experimental animals chemicals other than drugs . Teratogen Carcinogen Mutagen. 5:1985;251-318.
17. Ferm V.H. The teratogenic effects of metals on mammalian embryos. Adv Teratol. 5:1972;51-75.
18. Léonard A., Lauwerys R.R. Carcinogenicity, teratogenicity and mutagenicity of arsenic. Mutat Res. 75:1980;49-62.
19. Ferm V.H., Hanlon D.P. Metal-induced congenital malformations. Clarkson T.W., Nordberg G.F., Sager P.R. Reproductive and developmental toxicity of metals. 1983;383-397 Plenum, New York.
20. Goldman M., Dacre J.C. Inorganic arsenic compounds are they carcinogenic, mutagenic, teratogenic? Environ Geochem Health. 13:1991;179-191.
21. Domingo J.L. Metal-induced developmental toxicity in mammals a review . J Toxicol Environ Health. 42:1994;123-141.
22. Golub M.S. Maternal toxicity and the identification of inorganic arsenic as a developmental toxicant. Reprod Toxicol. 8:1994;283-295.
23. Shalat S.L., Walker D.B., Finnell R.H. Role of arsenic as a reproductive toxin with particular attention to neural tube defects. J Toxicol Environ Health. 48:1996;253-272.
24. Donald J.M., Monserrat L.E., Hooper K., Book S.A., Chernoff G.F. Prioritizing candidate reproductive/developmental toxicants for evaluation. Reprod Toxicol. 6:1992;99-108.
25. U. S. General Accounting Office (GAO). Reproductive and developmental toxicants: regulatory actions provide uncertain protection. GAO/PEMD-92-3. Washington: GAO; October 1991.
26. Vahter M. Species differences in the metabolism of arsenic compounds. Appl Organomet Chem. 8:1994;175-182.
27. National Research Council. Medical and biologic effects of environmental pollutants: arsenic. Washington: National Academy of Sciences; 1977.
28. International Programme on Chemical Safety (IPCS), World Health Organization (WHO). Environmental Health Criteria 18: arsenic. Geneva: WHO; 1981.
29. Wauchope R.D. Uptake, translocation and phytotoxicity of arsenic in plants. Lederer W.H., Fensterheim R.J. Arsenic: industrial, biomedical, environmental perspectives. 1983;348-377 Van Nostrand Reinhold, New York.
30. Uthus E.O. Estimation of safe and adequate daily intake for arsenic. Mertz W., Abernathy C.O., Olin S.S. Risk assessment of essential elements. 1994;273-282 ILSI, Washington.
31. Biddinger G.R., Gloss S.P. The importance of trophic transfer in the bioaccumulation of chemical contaminants in aquatic ecosystems. Residue Rev. 91:1984;103-145.
32. Phillips D.J.H. Arsenic in aquatic organisms a review, emphasizing chemical speciation . Aquatic Toxicol. 16:1990;151-186.
33. Borum D.R., Abernathy C.O. Human oral exposure to inorganic arsenic. Environ Geochem Health. 16:1994;21-30.
34. Valberg P.A., Beck B.D., Bowers T.S., Keating J.L., Bergstrom P.D., Boardman P.D. Issues in setting health-based cleanup levels for arsenic in soil. Regul Toxicol Pharmacol. 26:1997;219-229.
35. Gunderson E.L. FDA total diet study, July 1986-April 1991, dietary intakes of pesticides, selected elements, and other chemicals. J AOAC Int. 78:1995;1353-1363.
36. Tay C.H., Saeh C.S. Arsenic poisoning from anti-asthmatic herbal preparations. Med J Aust. 2:1975;424-428.
37. Kerr H.D., Saryan L.A. Arsenic content of homeopathic medicines. J Toxicol Clin Toxicol. 24:1986;451-459.
38. Stecher P.G. The Merck Index. 8th ed. 1968;Merck, Rahway, NJ.
39. Agency for Toxic Substances and Disease Registry (ATSDR), Centers for Disease Control and Prevention. Minimal risk levels for hazardous substances. Web page http://atsdr1.atsdr.cdc.gov:8080/mrls.html. January 1997.
40. Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention. Public health statement: arsenic. Web page http://atsdr1.atsdr.cdc.gov:8080/ToxProfiles/phs8802.html. March 1989.
41. Levine T, Rispin A, Scott CS, Marcus W, Chen C, Gibb H. Special report on ingested inorganic arsenic: skin cancer; nutritional essentiality. EPA/625/3-87/013. Washington: U. S. Environmental Protection Agency; July 1988.
42. Marafante E., Vahter M. Solubility, retention, and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster. Environ Res. 42:1987;72-82.
43. Mann S., Droz P.O., Vahter M. A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. Toxicol Appl Pharmacol. 140:1996;471-486.
44. Dallaire L., Beliveau R. Phosphate transport by capillaries of the blood-brain barrier. J Biol Chem. 267:1992;22323-22327.
45. Gonzalez M.J., Aguilar M.V., Martinez Para MC. Gastrointestinal absorption of inorganic arsenic (V) the effect of concentration and interactions with phosphate and dichromate . Vet Hum Toxicol. 37:1995;131-136.
46. Freeman G.B., Johnson J.D., Killinger J.M., et al. Bioavailability of arsenic in soil impacted by smelter activities following oral administration in rabbits. Fundam Appl Toxicol. 21:1993;83-88.
47. Freeman G.B., Schoof R.A., Ruby M.V., et al. Bioavailability of arsenic in soil and house dust impacted by smelter activities following oral administration in cynomolgus monkeys. Fundam Appl Toxicol. 28:1995;215-222.
48. McKinney J.D. Metabolism and disposition of inorganic arsenic in laboratory animals and humans. Environ Geochem Health. 14:1992;43-48.
49. 74As) in humans following oral ingestion. Toxicol Appl Pharmacol. 50:1979;319-322.
50. 74As-labeled trivalent and pentavalent inorganic arsenic in mice. Environ Res. 21:1980;446-457.
51. 74As]arsenic acid in the hamster. Toxicol Lett. 5:1980;175-182.
52. Odanaka Y., Matano O., Goto S. Biomethylation of inorganic arsenic by the rat and some laboratory animals. Bull Environ Contam Toxicol. 24:1980;452-459.
53. Vahter M. Metabolism of arsenic. Fowler B.A. Biological and environmental effects of arsenic. 1983;171-198 Elsevier, Amsterdam.
54. Vahter M. Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. Environ Res. 25:1981;286-293.
55. Hunter F.T., Kip A.F., Irvine J.W. Radioactive tracer studies on arsenic injected as potassium arsenite. J Pharmacol Exp Therapeutics. 76:1942;207-220.
56. 74As-arsenite. Arch Toxicol. 51:1982;65-77.
57. Vahter M., Couch R., Nermell B., Nilsson R. Lack of methylation of inorganic arsenic in the chimpanzee. Toxicol Appl Pharmacol. 133:1995;262-268.
58. Aposhian H.V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Ann Rev Pharmacol Toxicol. 37:1997;397-419.
59. Aposhian H.V., Zakharyan R.A., Healy S.M., et al. Biodiversity of inorganic arsenite methyltransferases. Toxicol Sci. 42S:1998;353.
60. Buchet J.P., Pauwels J., Lauwerys R. Assessment of exposure to inorganic arsenic following ingestion of marine organisms by volunteers. Environ Res. 66:1994;44-51.
61. Ramsey E.M. The placenta human and animal . 1982;Praeger, New York.
62. Miller R.K., Koszalka T.R., Brent R.L. Transport mechanisms for molecules across placental membranes. Poste G., Nicolson G.L. Cell surface reviews, vol. 1. The cell surface in animal embryogenesis and development. 1976;145-332 Elsevier/North-Holland, Amsterdam.
63. Miller R.K., Levin A.A., Ng W.W. The placenta relevance to toxicology . Clarkson T.W., Nordberg G.F., Sager P.R. Reproductive and developmental toxicity of metals. 1983;569-605 Plenum, New York.
64. Miller R.K. Placental transfer and function the interface for drugs and chemicals in the conceptus . Fabro S., Scialli A.R. Drug and chemical action in pregnancy pharmacologic and toxicologic principles . 1986;123-152 Marcel Dekker, New York.
65. Wild A.E. Endocytic mechanisms of protein transfer across the placenta. Placenta. 1:1981;165-186.
66. Eastman N.J. The arsenic content of the human placenta following arsphenamine therapy. Am J Obstet Gynecol. 21:1931;60-64.
67. Underhill F.P., Amatruda F.G. The transmission of arsenic from mother to fetus. J Am Med Assoc. 81:1923;2009-2012.
68. Snyder F.F., Speert H. The placental transmission of neoarsphenamine in relation to the stage of pregnancy. Am J Obstet Gynecol. 36:1938;579-586.
69. Kagey B.T., Bumgarner J.E., Creason J.P. Arsenic levels in maternal-fetal tissue sets. Trace Subst Environ Health. 11:1977;252-256.
70. Tabacova S., Baird D.D., Balabaeva L., Lolova D., Petrov I. Placental arsenic and cadmium in relation to lipid peroxides and glutathione levels in maternal-infant pairs from a copper smelter area. Placenta. 15:1994;873-881.
71. Tabocova S., Little R.E., Balabaeva L., Pavlova S., Petrov I. Complications of pregnancy in relation to maternal lipid peroxides, glutathione, and exposure to metals. Reprod Toxicol. 8:1994;217-224.
72. Dencker L., Danielsson B., Khayat A., Lindgren A. Disposition of metals in the embryo and fetus. Clarkson T.W., Nordberg G.F., Sager P.R. Reproductive and developmental toxicity of metals. 1983;607-631 Plenum, New York.
73. Lindgren A., Danielsson B.R.G., Dencker L., Vahter M. Embryotoxicity of arsenite and arsenate distribution in pregnant mice and monkeys and effects on embryonic cells in vitro . Acta Pharmacol Toxicol. 54:1984;311-320.
74. Grüneberg H. The development of some external features in mouse embryos. J Hered. 34:1943;88-92.
75. DeSesso J.M. Comparative embryology. Hood R.D. Handbook of developmental toxicology. 1997;111-174 CRC, Boca Raton.
76. Gerber G.B., Maes J., Eykens B. Transfer of antimony and arsenic to the developing organism. Arch Toxicol. 49:1982;159-168.
77. Hanlon D.P., Ferm V.H. Placental permeability of arsenate ion during early embryogenesis in the hamster. Experientia. 33:1977;1221-1222.
78. Everett J.W. Morphological and physiological studies of the placenta in the albino rat. J Exp Zool. 70:1935;243-280.
79. Boyer C.C. Chronology of development of the golden hamster. J Morphol. 92:1953;1-37.
80. Hamilton W.J., Mossman H.W. Hamilton, Boyd, and Mossman's human embryology: prenatal development of form and function. 4th ed. 1972;Williams & Wilkins, Baltimore.
81. Hood R.D., Vedel-Macrander G.C., Zaworotko M.J., Tatum F.M., Meeks R.G. Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or i.p. administration. Teratology. 35:1987;19-25.
82. Hood R.D., Vedel G.C., Zaworotko M.J., Tatum F.M., Meeks R.G. Uptake, distribution, and metabolism of trivalent arsenic in the pregnant mouse. J Toxicol Environ Health. 25:1988;423-434.
83. Buelke-Sam J., Nelson C.J., Byrd R.A., Holson J.F. Blood flow during pregnancy in the rat. I. Flow patterns to maternal organs. Teratology. 26:1982;269-277.
84. Buelke-Sam J., Nelson C.J., Byrd R.A., Holson J.F. Blood flow during pregnancy in the rat. II. Dynamics of and litter variability in uterine flow. Teratology. 26:1982;279-288.
85. Parisi V.M., Creasy R.K. Maternal biologic adaptations to pregnancy. Reece E.A., Hobbins J.C., Mahoney M.J., Petrie R.H. Medicine of the fetus and mother. 1992;831-848 JB Lippincott, Philadelphia.
86. Koren G. Changes in drug disposition in pregnancy and their clinical implications. Koren G. Maternal-fetal toxicology. 1994;3-14 Marcel Dekker, New York.
87. Goodman L., Gilman A. Drugs used in the chemotherapy of syphilis. I. The pharmacology and clinical toxicology of the antisyphilitic arsenicals: the arsphenamines, mapharsen, and tryparsamide. The pharmacological basis of therapeutics. 1941;946-977 MacMillan, New York.
88. Hoar R.M., Monie I.W. Comparative development of specific organ systems. Kimmel C.A., Buelke-Sam J. Developmental toxicology. 1981;13-33 Raven, New York.
89. Gregus Z., Klaassen C.D. Mechanisms of toxicity. Klaassen C.D. Casarett and Doull's toxicology: the basic science of poisons. 5th ed. 1996;35-74 McGraw-Hill, New York.
90. Goyer R.A. Toxic effects of metals. Klaassen C.D. Casarett and Doull's toxicology: the basic science of poisons. 5th ed. 1996;691-736 McGraw-Hill, New York.
91. Li W., Chou I.-N. Effects of sodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol Appl Pharmacol. 114:1992;132-139.
92. Mottet N.K., Ferm V.H. The congenital teratogenicity and perinatal toxicity of metals. Clarkson T.W., Nordberg G.F., Sager P.R. Reproductive and developmental toxicity of metals. 1983;95-125 Plenum, New York.
93. Hood R.D. Toxicology of prenatal exposure to arsenic. Lederer W.H., Fensterheim R.J. Arsenic: industrial, biomedical, environmental perspectives. 1983;134-150 Van Nostrand Reinhold, New York.
94. Stump D.G., Fleeman T.L., Nemec M.D., Holson J.F., Farr C.H. Evaluation of the teratogenicity of sodium arsenate and arsenic trioxide following single oral or intraperitoneal administration in rats. Teratology. 57:1998;217.
95. Stump D.G., Clevidence K.J., Knapp J.F., Holson J.F., Farr C.H. An oral developmental toxicity study of arsenic trioxide in rats. Teratology. 57:1998;216-217.
96. Stump D.G., Ulrich C.E., Holson J.F., Farr C.H. An inhalation developmental toxicity study of arsenic trioxide in rats. Teratology. 57:1998;216.
97. WIL Research Laboratories, Inc. A teratology study in mice with arsenic acid (75%). Sponsored by Pennwalt Corp. 1988.
98. Hood RD, Nemec MD, Holson JF, Farr CH. Effects of mid-gestational exposure of mice and rabbits to arsenic acid. Toxicol Sci. 1998;42S:258, full manuscript in preparation.
99. Henwood SM. Two-generation dietary reproduction study with arsenic acid in mice. Sponsored by Pennwalt Corp., performed by Hazleton Laboratories America, Inc., 1990.
100. WIL Research Laboratories, Inc. A teratology study in rabbits with arsenic acid (75%). Sponsored by Pennwalt Corp. 1988.
101. Lange N.A. Handbook of chemistry. 10th ed. 1967;McGraw-Hill, New York.
102. Ferm V.H., Carpenter S.J. Malformations induced by sodium arsenate. J Reprod Fert. 17:1968;199-201.
103. Holmberg R.E. Jr, Ferm V.H. Interrelationships of selenium, cadmium, and arsenic in mammalian teratogenesis. Arch Environ Health. 18:1969;873-877.
104. Ferm V.H., Saxon A., Smith B.M. The teratogenic profile of sodium arsenate in the golden hamster. Arch Environ Health. 22:1971;557-560.
105. Willhite C.C. Arsenic-induced axial skeletal (dysraphic) disorders. Exp Mol Pathol. 34:1981;145-158.
106. Carpenter S.J. Developmental analysis of cephalic axial dysraphic disorders in arsenic-treated hamster embryos. Anat Embryol. 176:1987;345-366.
107. Hood R.D., Harrison W.P. Effects of prenatal arsenite exposure in the hamster. Bull Environ Contam Toxicol. 29:1982;671-678.
108. Hood R.D., Harrison W.P., Vedel G.C. Evaluation of arsenic metabolites for prenatal effects in the hamster. Bull Environ Contam Toxicol. 29:1982;679-687.
109. Willhite C.C., Ferm V.H. Prenatal and developmental toxicology of arsenicals. Adv Exp Med Biol. 177:1984;205-228.
110. Harris S.B., DeSesso J.M. Practical guidance for evaluating and interpreting developmental toxicity tests. J Hazardous Materials. 39:1994;245-266.
111. Beaudoin A.R. Teratogenicity of sodium arsenate in rats. Teratology. 10:1974;153-158.
112. Burk D., Beaudoin A.R. Arsenate-induced renal agenesis in rats. Teratology. 16:1977;247-260.
113. Mason R.W., Edwards I.R., Fisher L.C. Teratogenicity of combinations of sodium dichromate, sodium arsenate and copper sulphate in the rat. Comp Biochem Physiol. 93C:1989;407-411.
114. Hood R.D., Thacker G.T., Patterson B.L. Effects in the mouse and rat of prenatal exposure to arsenic. Environ Health Perspect. 19:1977;219-222.
115. Umpierre C.C. Embryolethal and teratogenic effects of sodium arsenite in rats. Teratology. 23:1981;66A.
116. Kojima H. Studies on developmental pharmacology of arsenic. 2. Effect of arsenite on pregnancy, nutrition and hard tissue. Folia Pharmacol. Japon. 70:1974;149-163.
117. American Council of Governmental and Industrial Hygienists (ACGIH). Threshold limit values and biologic exposure indices for 1997. Cincinnati: ACGIH; 1997.
118. Morrissey R.E., Fowler B.A., Harris M.W., Moorman M.P., Jameson C.W., Schwetz B.A. Arsine absence of developmental toxicity in rats and mice . Fundam Appl Toxicol. 15:1990;350-356.
119. Rogers E.H., Chernoff N., Kavlock R.J. The teratogenic potential of cacodylic acid in the rat and mouse. Drug Chem Toxicol. 4:1981;49-61.
120. Nadeenko V.G., Lenchenko V.G., Genkina S.B., Arkhipenko T.A. Effect of tungsten, molybdenum, copper and arsenic on the intrauterine development of the foetus. Farmakol Toksikol (Moscow). 41:1978;620-623.
121. Takeuchi I.K. Embryotoxicity of arsenic acid light and electron microscopy of its effect on neurulation-stage rat embryo . J Toxicol Sci. 4:1979;405-416.
122. Hood R.D., Bishop S.L. Teratogenic effects of sodium arsenate in mice. Arch Environ Health. 24:1972;62-65.
123. Hood R.D., Pike C.T. BAL alleviation of arsenate-induced teratogenesis in mice. Teratology. 6:1972;235-238.
124. Hood R.D., Thacker G.T., Patterson B.L., Szczech G.M. Prenatal effects of oral vs. intraperitoneal sodium arsenate in mice. J Environ Pathol Toxicol. 1:1978;857-864.
125. Morrissey R.E., Mottet N.K. Arsenic-induced exencephaly in the mouse and associated lesions occurring during neurulation. Teratology. 28:1983;399-411.
126. Matsumoto N., Okino T., Katsunuma H., Iijima S. Effects of Na-arsenate on the growth and development of the foetal mice. Teratology. 8:1973;98.
127. Seidenberg J.M., Anderson D.G., Becker R.A. Validation of an in vivo developmental toxicity screen in the mouse. Teratogen Carcinogen Mutagen. 6:1986;361-374.
128. Murakami U. Comparative pathological development of the central nervous system. Nishimura H., Miller J.R. Methods for teratological studies in experimental animals and man. 1968;136-145 Igaku Shoin, Tokyo.
129. Hood R.D., Baxley M.N., Harrison W.P. Evaluation of chromated copper arsenate (CCA) for teratogenicity. Teratology. 19:1979;31A.
130. Hood R.D. Effects of sodium arsenite on fetal development. Bull Environ Contam Toxicol. 7:1972;216-222.
131. Hood R.D., Vedel-Macrander G.C. Evaluation of the effect of BAL (2,3-dimercaptopropanol) on arsenite-induced teratogenesis in mice. Toxicol Appl Pharmacol. 73:1984;1-7.
132. Baxley M.N., Hood R.D., Vedel G.C., Harrison W.P., Szczech G.M. Prenatal toxicity of orally administered sodium arsenite in mice. Bull Environ Contam Toxicol. 26:1981;749-756.
133. Schroeder H.A., Mitchener M. Toxic effects of trace elements on the reproduction of mice and rats. Arch Environ Health. 23:1971;102-106.
134. Nagymajtényi L., Selypes A., Berencsi G. Chromosomal aberrations and fetotoxic effects of atmospheric arsenic exposure in mice. J Appl Toxicol. 5:1985;61-63.
135. Harrison W.P., Frazier J.C., Mazzanti E.M., Hood R.D. Teratogenicity of disodium methanearsonate and sodium dimethylarsinate (sodium cacodylate) in mice. Teratology. 21:1980;43A.
136. Ma L., Zhang C., Liu W.J., et al. Effects of arsenic on the offspring development in mice. Chung-Hua-Yu-Fang-I-Hsueh-Tsa-Chih. 28:1994;20-23.
137. Seidenberg J.M., Becker R.A. A summary of the results of 55 chemicals screened for developmental toxicity in mice. Teratogen Carcinogen Mutagen. 7:1987;17-28.
138. James L.F., Lazar V.A., Binns W. Effects of sublethal doses of certain minerals on pregnant ewes and fetal development. Am J Vet Res. 27:1966;132-135.
139. Wilson J.G. Environment and birth defects. 1973;Academic, New York.
140. Beckman D.A., Brent R.L. Basic principles of teratology. Reece E.A., Hobbins J.C., Mahoney M.J., Petrie R.H. Medicine of the fetus and mother. 1992;293-299 JB Lippincott, Philadelphia.
141. DeSesso J.M., Harris S.B. Principles underlying developmental toxicity. Fan A.M., Chang L.W. Toxicology and risk assessment: principles, methods, and applications. 1996;37-56 Marcel Dekker, New York.
142. Wilson J.G. Embryological considerations in teratology. Wilson J.G., Warkany J. Teratology principles and techniques . 1965;251-261 University of Chicago, Chicago.
143. Moore K.L., Persaud T.V.N. The developing human clinically oriented embryology . 5th ed. 1993;WB Saunders, Philadelphia.
144. Sadler T.W. Langman's medical embryology. 7th ed. 1995;Williams & Wilkins, Baltimore.
145. Larsen W.J. Human embryology. 2nd ed. 1997;Churchill Livingstone, New York.
146. Mirkes P.E., Cornel L. A comparison of sodium arsenite- and hyperthermia-induced stress responses and abnormal development in cultured postimplantation rat embryos. Teratology. 46:1992;251-259.
147. Tabocova S., Hunter E.S. 3rd, Gladen B.C. Developmental toxicity of inorganic arsenic in whole embryo culture oxidation state, dose, time, and gestational age dependence . Toxicol Appl Pharmacol. 138:1996;298-307.
148. Chaineau E., Binet S., Pol D., Chatellier G., Meininger V. Embryotoxic effects of sodium arsenite and sodium arsenate on mouse embryos in culture. Teratology. 41:1990;105-112.
149. Müller W.U., Streffer C., Fischer-Lahdo C. Toxicity of sodium arsenite in mouse embryos in vitro and its influence on radiation risk. Arch Toxicol. 59:1986;172-175.
150. Sadler T.W., Shum L., Warner C.W., Smith M.K. The role of pharmacokinetics in determining the response of rodent embryos to teratogens in whole-embryo culture. Toxicol in Vitro. 2:1988;175-180.
151. Schwetz B.A. In vitro approaches in developmental toxicology. Reprod Toxicol. 7S:1993;125-127.
152. Beaudoin A.R., Fisher D.L. An in vivo/in vitro evaluation of teratogenic action. Teratology. 23:1981;57-61.
153. Fisher D.L. Cultured rat embryo accumulation of DNA, RNA, and protein following maternal administration of sodium arsenate. Environ Res. 28:1982;1-9.
154. Ancel P., Lallemand S. Sur l'arrêt de développement du bourgeon caudal obtenu expérimentalement chez l'embryon de poulet. Arch Physique Biol. 15:1941;27-29.
155. Ancel P. Recherche expérimentale sur le spina bifida. Arch Anat microsc Morph Exp. 1946-1947;36:45-68.
156. Ridgway L.P., Karnofsky D.A. The effects of metals on the chick embryo toxicity and production of abnormalities in development . Ann NY Acad Sci. 55:1952;203-215.
157. Birge W.J., Roberts O.W. Toxicity of metals to chick embyros. Bull Environ Contam Health. 16:1976;319-324.
158. Peterková R., Puzanová L. Effect of trivalent and pentavalent arsenic on early developmental stages of the chick embryo. Folia Morphol. 24:1976;5-13.
159. Gilani S.H., Alibhai Y. Teratogenicity of metals to chick embryos. J Toxicol Environ Health. 30:1990;23-31.
160. Puzanová L., Doskocil M. Mechanism of the development of malformations in chick embryos after administration of arsenic. Sborník Lékarský 78:1976;57-63.
161. Albert A. Selective toxicity the physico-chemical basis of therapy . 6th ed. 1981;Chapman and Hall, London.
162. Bolliger C.T., van Zijl P., Louw J.A. Multiple organ failure with the adult respiratory distress syndrome in homicidal arsenic poisoning. Respiration. 59:1992;57-61.
163. Lugo G., Cassady G., Palmisano P. Acute maternal arsenic intoxication with neonatal death. Am J Dis Child. 117:1969;328-330.
164. Daya M.R., Irwin R., Parshley M.C., Harding J., Burton B.T. Arsenic ingestion in pregnancy. Vet Hum Toxicol. 31:1989;347.
165. Kantor H.I., Levin P.M. Arsenical encephalopathy in pregnancy with recovery. Am J Obstet Gynecol. 56:1948;370-374.
166. Ihrig MM. Effect of chronic inhalation of inorganic arsenic on the risk of stillbirth in a community surrounding an agriculture chemical production facility: a hospital-based study. Thesis, Texas A&M University, 1997.
167. Ihrig MM, Shalat SL, Baynes C. Risk of stillbirth in a community surrounding an arsenical based agriculture chemical production facility. Am J Epidemiol. 1997;145: abstract 77. Published in full after this submission as Ihrig MM, Shalat SL, Baynes C. A hospital-based case-control study of stillbirths and environmental exposure to arsenic using an atmospheric dispersion model linked to a geographical information system. Epidemiol. 1998;9:290-4.
168. Ihrig MM, Shalat SL, Baynes C. Risk of stillbirth in a community surrounding an arsenical based agriculture chemical production facility. Am J Epidemiol. 1997;145: abstract 77. Published in full after this submission as Ihrig MM, Shalat SL, Baynes C. A hospital-based case-control study of stillbirths and environmental exposure to arsenic using an atmospheric dispersion model linked to a geographical information system. Epidemiol. 1998;9:290-4.
169. Zierler S., Theodore M., Cohen A., Rothman K.J. Chemical quality of maternal drinking water and congenital heart disease. Int J Epidemiol. 17:1988;589-594.
170. Aschengrau A., Zierler S., Cohen A. Quality of community drinking water and the occurrence of spontaneous abortion. Arch Environ Health. 44:1989;283-290.
171. Office of Ground Water & Drinking Water, U. S. Environmental Protection Agency. National primary drinking water standards. Web page http://www.epa.gov/OGWDW/wot/appa.html. February. 1998.
172. Börzsönyi M., Bereczky A., Rudnai P., Csanady M., Horvath A. Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary [letter]. Arch Toxicol. 66:1992;77-78.
173. Nordström S., Beckman L., Nordenson I. Occupational and environmental risks in and around a smelter in northern Sweden. I. Variations in birth weight. Hereditas. 88:1978;43-46.
174. Nordström S., Beckman L., Nordenson I. Occupational and environmental risks in and around a smelter in northern Sweden. III. Frequencies of spontaneous abortion. Hereditas. 88:1978;51-54.
175. Nordström S., Beckman L., Nordenson I. Occupational and environmental risks in and around a smelter in northern Sweden. V. Spontaneous abortion among female employees and decreased birth weight in their offspring. Hereditas. 90:1979;291-296.
176. Nordström S., Beckman L., Nordenson I. Occupational and environmental risks in and around a smelter in northern Sweden. VI. Congenital malformations. Hereditas. 90:1979;297-302.
177. Beckman L., Nordström S. Occupational and environmental risks in and around a smelter in northern Sweden. IX. Fetal mortality among wives of smelter workers. Hereditas. 97:1982;1-7.
178. Texas Department of Health. An investigation of a cluster of neural tube defects in Cameron County, Texas. July 1992.
179. Anonymous. Arsenic-eaters. Boston Med Surg J. 51:1854;189-195.
180. Roscoe H.E. On the alleged practice of arsenic-eating in Styria. Mem Lit Phil Soc Manchester. 3xs.,i:1862;208-221.
181. Maclagen C. On the arsenic-eaters of Styria. Edinburgh Med J. 10:1864;200-207.
182. Maclagen R.C. Arsenic-eaters of Styria. Edinburgh Med J. 21:1875;526-528.
183. Reynolds E.S. An account of the epidemic outbreak of arsenical poisoning occurring in beer-drinkers in the north of England and the midland counties in 1900. Lancet. 1:1901;166-170.
184. Mizuta N., Mizuta M., Ito F., et al. An outbreak of acute arsenic poisoning caused by arsenic contaminated soy-sauce (shoyu) a clinical report of 220 cases . Bull Yamaguchi Med School. 4:1956;131-149.
185. Tseng W.P., Chu H.M., How S.W., Fong J.M., Lin C.S., Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J National Cancer Inst. 40:1968;453-463.
186. Ch'i I., Blackwell R.Q. A controlled retrospective study of Blackfoot disease, an endemic peripheral gangrene disease in Taiwan. Am J Epidemiol. 88:1968;7-24.
187. Zaldívar R. Arsenic contamination of drinking water and foodstuffs causing endemic chronic poisoning. Beitr Pathol. 151:1974;384-400.
188. Vahter M., Concha G., Nermell B., Nilsson R., Dulout F., Natarajan A.T. A unique metabolism of inorganic arsenic in native Andean women. Eur J Pharmacol (Environ Toxicol Pharmacol Section). 293:1995;455-462.
189. Birmingham D.J., Key M.M., Holaday D.A., Perone V.B. An outbreak of arsenical dermatoses in a mining community. Arch Dermatol. 91:1965;457-464.
190. Nelson W.C., Lykins M.H., Mackey J., Newill V.A., Finklea J.F., Hammer D.I. Mortality among orchard workers exposed to lead arsenate spray a cohort study . J Chron Dis. 26:1973;105-118.
191. Milham S., Strong T. Human arsenic exposure in relation to a copper smelter. Environ Res. 7:1974;176-182.
192. U. S. Environmental Protection Agency. Guidelines for developmental toxicity risk assessment. Federal Register. 1991;56:63798-826.
193. Nelson C.J., Holson J.F. Statistical analysis of teratologic data problems and advancements . J Environ Pathol Toxicol. 2:1978;187-199.
194. Ferm V.H., Hanlon D.P. Constant rate exposure of pregnant hamsters to arsenate during early gestation. Environ Res. 37:1985;425-432.
195. Hanlon D.P., Ferm V.H. Concentration and chemical status of arsenic in the blood of pregnant hamsters during critical embryogenesis. 1. Subchronic exposure to arsenate utilizing constant rate administration. Environ Res. 40:1986;372-379.
196. Hanlon D.P., Ferm V.H. Concentration and chemical status of arsenic in the blood of pregnant hamsters during critical embryogenesis. 2. Acute exposure. Environ Res. 40:1986;380-390.
197. Hanlon D.P., Ferm V.H. The concentration and chemical status of arsenic in the early placentas of arsenate-dosed hamsters. Environ Res. 42:1987;546-552.
198. Davis A., Ruby M.V., Bergstrom P.D. Bioavailability of arsenic and lead in soils from the Butte, Montana district. Environ Sci Technol. 26:1992;461-468.
199. Dorland's Illustrated Medical Dictionary. 24th ed. 1965;WB Saunders, Philadelphia.
200. Warkany J. Congenital malformations notes and comments . 1971;Year Book Medical, Chicago.
201. Lemire R.J., Beckwith J.B., Warkany J. Anencephaly. 1978;Raven, New York.
202. Congenital malformations worldwide. 1991;Elsevier, Amsterdam.
203. Padmanabhan R. Is exencephaly the forerunner of anencephaly? Acta Anat (Basel). 141:1991;182-192.
204. Wise L.D., Beck S.L., Beltrame D., et al. Terminology of developmental abnormalities in common laboratory mammals (version I). Teratology. 55:1997;249-292.
205. Weast R.C. CRC handbook of chemistry and physics. 58th ed. 1977;CRC, Cleveland.